A convenient method to pre-screen candidate guide RNAs for CRISPR/Cas9 gene editing by NHEJ-mediated integration of a 'self-cleaving' GFP-expression plasmid. by Tálas, András et al.
Full Paper
A convenient method to pre-screen candidate
guide RNAs for CRISPR/Cas9 gene editing by
NHEJ-mediated integration of a ‘self-cleaving’
GFP-expression plasmid
Andras Talas1,2, Pe´ter Istvan Kulcsar2,3,4, Nora Weinhardt2,3,4,
Adrienn Borsy2, Eszter Toth2,3, Korne´lia Szebe´nyi2,
Sarah Laura Krausz1,2, Krisztina Huszar2,3, Istvan Vida2,5, Adam Sturm2,
Bianka Gordos2, Orsolya Ivett Hoffmann6, Petra Bencsura2,3,
Antal Nyeste2,3, Zoltan Ligeti2, Elfrieda Fodor3, and Ervin Welker2,3,*
1School of Ph.D. Studies, Semmelweis University, Budapest, Hungary, 2Institute of Enzymology, Research Centre
for Natural Sciences of the Hungarian Academy of Sciences, Budapest, Hungary, 3Institute of Biochemistry,
Biological Research Centre of the Hungarian Academy of Sciences, Szeged, Hungary, 4University of Szeged,
Szeged, Hungary, 5Institute of Organic Chemistry, Eo¨tvo¨s Lorand University, Budapest, Hungary, and 6Animal
Biotechnology Section, Ruminant Genome Biology Group, NARIC Agricultural Biotechnology Institute, Go¨do¨ll}o,
Hungary
*To whom correspondence should be addressed. Tel. þ361 382 6610. Email: welker.ervin@ttk.mta.hu
Edited by Dr. Toshihiko Shiroishi
Received 29 November 2016; Editorial decision 27 May 2017; Accepted 7 June 2017
Abstract
The efficacies of guide RNAs (gRNAs), the short RNA molecules that bind to and determine the
sequence specificity of the Streptococcus pyogenes Cas9 nuclease, to mediate DNA cleavage
vary dramatically. Thus, the selection of appropriate target sites, and hence spacer sequence, is
critical for most applications. Here, we describe a simple, unparalleled method for experimen-
tally pre-testing the efficiencies of various gRNAs targeting a gene. The method explores NHEJ-
cloning, genomic integration of a GFP-expressing plasmid without homologous arms and
linearized in-cell. The use of ‘self-cleaving’ GFP-plasmids containing universal gRNAs and corre-
sponding targets alleviates cloning burdens when this method is applied. These universal
gRNAs mediate efficient plasmid cleavage and are designed to avoid genomic targets in several
model species. The method combines the advantages of the straightforward FACS detection
provided by applying fluorescent reporter systems and of the PCR-based approaches being ca-
pable of testing targets in their genomic context, without necessitating any extra cloning steps.
Additionally, we show that NHEJ-cloning can also be used in mammalian cells for targeted inte-
gration of donor plasmids up to 10 kb in size, with up to 30% efficiency, without any selection
or enrichment.
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1. Introduction
The use of RNA-guided nucleases revolutionized our ability to mod-
ify complex genomes and to control gene expression networks, in the
same manner that PCR revolutionized molecular biology at the end
of the 20th century.1–10 The specificity of Cas9 nucleases is deter-
mined in part by the so-called spacer sequence of the guide RNA
(gRNA) associated to the protein and responsible for target recogni-
tion. This makes the Cas9 proteins easily reprogrammable by simply
varying the sequence of the spacer.1 This attractive feature of the
Cas9 nucleases has been exploited for genome editing and gene ex-
pression modulation, as well as for generating disease and therapeu-
tic models.7,9,11–15
The efficiencies of various gRNA spacers to result targeted DNA
cleavage by Cas9 vary widely. While several sequence determinants
of efficient target recognition for Streptococcus pyogenes Cas9
(SpCas9), have been revealed,16–21 an adequate prediction of the effi-
ciency of a given spacer sequence has not been achieved, partially be-
cause the activity of a gRNA may be modulated by the genomic
context of the target: a factor difficult to predict.22,23 Generally, sev-
eral candidate spacer sequences are tested before choosing the appro-
priate ones for performing the desired genetic modifications. Existing
methods to test the efficiency of a given spacer sequence commonly
measure the sequence alterations acquired during the repair of the
cleaved DNA.24 Breaks in the DNA involving one or both strands
are effectively repaired by the cell using one of the two main repair
pathways: the homologous recombination (HR) or the more error-
prone non-homologous end-joining (NHEJ).25 NHEJ-dependent re-
pair of double strand breaks frequently leads to small insertions or
deletions (indels), the frequency of which can be explored to monitor
the efficiency of Cas9 cleavage.26–28 Accordingly, many methods rely
on the assessment of indel frequencies that are usually determined by
PCR amplification of the corresponding region followed by
Surveyor/T7E1 nuclease assays,29 high resolution melt analysis,30,31
fluorescent PCR-capillary gel electrophoresis32 and direct33 or
deep11,12,34 sequencing. Alternatively, a large number of clones can
be sequenced upon the PCR amplification of the regions of interest.
The occurrence of HR events as a result of HR repair can also be
monitored by analysing clones using PCR followed by restriction di-
gestion35 or by sequencing,34 as well as by Southern blotting36–38 of
genomic DNA. As another approach, reporter assays are explored
for detecting HR events: (I) where a fluorescent signal is measured as
a result of recombination events correcting a truncated fluorescent
protein;39,40 (II) or where a fluorescent protein expression cassette is
incorporated at the cleavage site - at the cost of the laborious con-
struction of homologous arms.41 In case of exploiting NHEJ repair,
reporter assays are also frequently employed for monitoring indel
events that alter the reading frame of a fluorescent protein, resulting
in either loss or recovery of the fluorescent signal.35,39,42 Reporter as-
says that enable the use of fluorescence activated cell sorting (FACS)
to monitor the repair of double strand breaks are convenient, making
genomic DNA isolation and PCR amplification -including the some-
times very tedious condition/primer optimization- unnecessary. They
also provide more accurate estimations than Surveyor/T7E1 assays
and are much less expensive than deep sequencing.24 However, these
approaches generally require extra cloning steps to become applica-
ble to a particular task and lose the advantage of PCR-based meth-
ods of being capable of monitoring spacer efficiency in the genomic
context of the particular targets.
Here, we introduce a reporter assay, which requires no additional
cloning steps and is capable of testing spacer efficiencies on targets
within their genomic context. The method explores NHEJ-cloning
(NHEJ repair mediated integration) of a GFP-expression cassette to
a target site that is cleaved by SpCas9. The key feature of this ap-
proach is the use of a ‘self-cleaving’ plasmid that enhances targeted
integration.
Using SpCas9 and a self-cleaving plasmid, we also demonstrate a
very convenient and effective way of inserting relatively large DNA
fragments into the mammalian genome. NHEJ-cloning has been de-
scribed in zebrafish, using transcription activator-like effector nucle-
ase (TALEN) and SpCas9, and in mammalian cells, using zinc-finger
nuclease (ZFN) and TALEN.38,43,44 There have been a few attempts
to use SpCas9 for NHEJ-cloning of larger DNA cassettes in mamma-
lian cells as well,45,46 however, they achieved integrations at a rela-
tively low frequency, typically under 1% without selection or FACS-
enrichment. Here, we achieved a frequency that is greater by over an
order of magnitude. Thus, this approach facilitates the implementa-
tion of several genome engineering tasks in mammalian systems,
making them less labor-intensive, especially so regarding the inser-
tion of expression cassettes to safe-harbour locations in contrast
with the use of random integration.
2. Materials and methods
2.1. Materials
All restriction enzymes, Klenow polymerase and T4 ligase were ac-
quired from Thermo Scientific, Q5 and Phusion polymerases T7 en-
donuclease I, and Gibson Assembly Master Mix were from New
England Biolabs Inc. Oligonucleotides were purchased from
Microsynth AG and Sigma-Aldrich Co. and their sequences are listed
in the Supplementary Data. Dulbecco’s modified Eagle’s Medium,
foetal bovine serum, Turbofect, Lipofectamine 2000, GlutaMAX,
penicillin, streptomycin and puromycin were acquired from Thermo
Fisher Scientific, and trimethoprim (TMP) from Sigma-Aldrich Co.
(T7883).
2.2. Vector constructions
Briefly, SpCas9-gRNA expressing plasmids (targeting human and
mouse genes and also containing TL1 and TL2 spacers) were gener-
ated from the px330 vector (Addgene # 422303), and cloning spacers
into pmCherry_gRNA plasmid was conducted according to Hanhui
Ma et al.47 The construction of pmCherry_gRNA, pX330-Flag-
ehSpCas9 and pX330-Flag-wtSpCas9 is described in (Kulcsar et al.
2017 submitted). The nuclease inactive SpCas9 (dCas9) expressing
plasmid was created from px335 (Addgene #423353) by using Body
Double cloning method.48 The self-cleaving plasmids were created
by using Gibson assembly method. The self-cleaving plasmid con-
taining a puromycin cassette (pSc1-puro) was constructed by using
pLKO.1puro plasmid (Addgene #845349). The self-cleaving plasmid
with a degradation domain (pSc1-DD) was created from pBMN
DHFR(DD)-YFP plasmid (Addgene #2932550). The Prnp gene tar-
geting homologous recombination donor plasmid was created by us-
ing nested PCR. The Rosa26 locus homologous recombination
donor plasmid was created by using pDonor-MCS-rosa26 plasmid
[Addgene #3720051]. For more detailed information see
Supplementary Materials and Methods. The sequences of all plasmid
constructs were confirmed by Sanger sequencing (Microsynth AG).
2.3. Cell culture and transfection
All cell lines, Neuro-2a (CCL-131), HeLa (CCL-2), NIH/3T3 (CRL-
1658), and HEK293 (CRL-1573)—all from ATCC, were maintained
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in Dulbecco’s modified Eagle’s Medium supplemented with 10% fe-
tal bovine serum, 2 mM GlutaMAX, 100 U/ml penicillin, and
100lg/ml streptomycin at 37 C in a 5% CO2 in air and humidified
atmosphere. All cell lines were checked regularly and before the ex-
periments for mycoplasma infection.
2.4. Experiments with pSc1, pSc2 plasmids, and HDR
assays
Cells were seeded at 1.5105 cells/well in the case of HeLa, Neuro-
2a (N2a) and HEK293 cells, and at 3105 cells/well density for
NIH/3T3 cells, on 6-well plates 1 day prior to transfection. Cells
were transfected by 2 mg total DNA/well, combining 1 mg Cas9-
gRNA vector and 1 mg GFP vector DNAs (pSc1, pSc2, pHR-PRNP,
pHR-ROSA), and using either Turbofect at 3 ml/mg total DNA (in the
case of HeLa, N2a, and HEK293 cells) or Lipofectamine 2000 at
4.5 ml/mg total DNA (in the case of NIH/3T3 cells). Transfected cells
were passaged at a 1:10 ratio until confluency reached 80–100%
and the excess cells were analysed by FACS. The passaging contin-
ued until the transient expression disappeared (typically 12–15 days
post transfection). Transfection efficiency was determined on the sec-
ond day after transfection by measuring the fraction of GFP positive
cells (the values obtained were considered 100%) and was later used
to normalize the corresponding sample data. All transfections were
made in triplicates.
2.5. Coupled integration of the GFP and puromycin
cassettes
Before performing the experiments, the lowest antibiotic concentra-
tion that kills all non-transfected N2a cells was determined by apply-
ing increasing concentrations of antibiotic, up to 3.1 mg/ml
puromycin. A concentration of 0.7 mg/ml was the lowest that killed
all cells after 2 weeks of selection. This concentration was used fur-
ther for selection. N2a cells were co-transfected in four replicates
with pSc1-puro and pten specific Cas9-gRNA plasmid, using the pre-
viously described protocol with the pSc1 plasmid. As a control for
random integration, pSc1-puro was co-transfected with a plasmid
harbouring an inactive SpCas9 cassette (dCas9). Non-transfected
control cells were also used to monitor selection effectiveness.
Puromycin selection was started 2 days after transfection and on
days 2 and 12 post-transfection the number of GFP positive cells
were measured by FACS.
2.6. Experiments with pSc1-DD
Transfection was performed similarly as above with pSc1 plasmid,
except now 1 mg Cas9-gRNA, 300 ng pSc1-DD, and 300 ng
mCherry expressing plasmids were used per well for transfection on
6-well plates. Transfection efficiencies were determined 2 days after
transfection by measuring the fraction of mCherry positive cells (the
values obtained were considered 100%) and was later used to nor-
malize the corresponding sample data. TMP (1 mM) was added to
the media 24 h before FACS analysis.
2.7. Experiments with eSpCas9
A gRNA and mCherry coding plasmid (pmCherry_gRNA) was co-
transfected with a wtSpCas9 or eSpCas9 coding plasmid (pX330-
Flag-ehSpCas9 or pX330-Flag-wtSpCas9, respectively) and with the
pSc1 self-cleaving plasmid into N2a cells. Transfection was per-
formed similarly as with the pSc1 plasmid above, except now 760 ng
Cas9 coding, 760 ng pSc1 and 480 ng pmCherry_gRNA plasmid
was used. Transfection efficiencies were determined 2 days after
transfection by measuring the fraction of GFP positive cells (the val-
ues obtained were considered 100%) and was later used to normalize
the corresponding sample data.
2.8. Isolation of genomic DNA and genomic PCR
Genomic DNA from 1106 cells was isolated after stable GFP-
cassette integration (typically 12–15 days after transfection) using
PureLinkTM Genomic DNA Mini Kit (Invitrogen) following the man-
ufacturer’s protocol or by following Gentra DNA purification proto-
col (Gentra Puregen Handbook, Qiagen). From the isolated genomic
DNA PCR was conducted with Q5 polymerase (for PCR primers
and conditions, see Supplementary Data).
2.9. TIDE and T7 endonuclease I assay
Genomic PCR products were gel excised, purified via NucleoSpinVR
Gel and PCR Clean-up kit and were Sanger sequenced by
Microsynth AG. Indel efficiencies were analysed by TIDE web tool33
(https://tide.nki.nl/) by comparing Cas9 treated and control samples.
Samples of 200 ng from the same PCR reactions that were
analysed by TIDE were digested with five units of T7 endonuclease I
for 2 h at 37 C and were then analysed by agarose gel electrophore-
sis. Densitometry assessment of cleaved and uncleaved bands were
conducted with ImageJ software and the following formula was used
to determine InDel efficiency: InDel¼100*(1  (1  (bþ c)/(aþb þ
c))0.5), where b and c represent the cleaved products and a represents
the uncleaved band.
2.10. Statistics
Differences between groups were tested for statistical significance in
each experiment using one-way ANOVA test with Bonferroni’s post-
hoc test (IBM SPSS Statistics v.21).
2.11. Flow cytometry
Flow cytometry analysis was carried out on an Attune Acoustic
Focusing Cytometer (Applied Biosystems by Life Technologies).
Attune Cytometric Software was used for data analysis. In all experi-
ments, a total of 10,000 events were acquired and viable single cells
were gated based on side and forward light-scatter parameters. The
GFP signal was detected using a 488 nm diode laser for excitation
and a 530/30 nm filter for emission and the mCherry fluorescent sig-
nal was detected using a 488 nm diode laser for excitation and a
640LP filter for emission.
3. Results
3.1. In-cell cleavage of a GFP-plasmid facilitates moni-
toring of gRNA efficiencies
We aimed to compare the DNA double strand break mediating effi-
ciencies of different gRNAs with SpCas9. To this end, we measured
the fluorescence intensities associated with GFP expression cassettes
captured by the NHEJ repair system at the corresponding sites of the
double strand breaks. Here, our main concern was whether NHEJ-
mediated integration would sufficiently be efficient to be discernible
by fluorescence-detection from the random integration background
of the GFP cassette. To test this, first, we co-transfected N2a mouse
neuroblastoma cells with a circular GFP expression vector (pEGFP-
C1 - referred to as GFP-plasmid) along with the SpCas9 and gRNA
expressing vectors, and monitored the integration events by the
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fluorescence of GFP after transfection. As a control, a nuclease inac-
tive SpCas9 (dCas9) expressing plasmid was employed that allowed
to monitor the decay of the fluorescent signal originating from tran-
sient expression and facilitated determination of targeted integration
as being the signal detected above the background, non-targeted,
random integration of the expression cassette.
Five spacer sequences targeting three genes in the mouse genome,
three for Prnp, one for Sprn and one for Piwil4 genes, were selected
and the corresponding expression constructs with SpCas9 and
gRNAs were co-transfected with the GFP-plasmid into N2a cells.
Cells displaying GFP fluorescence were monitored by FACS until the
signal derived from transient expression has decayed and the fluores-
cence stabilized. This occurred over a 12–15-day period in all experi-
ments (Supplementary Fig. S1), depending on factors such as
transfection efficiency, which could be determined by measuring the
GFP fluorescence on the second day after transfection. Given that the
level of stabilized fluorescence varies from experiment to experiment,
all samples to be compared were tested side by side in these studies.
In these experiments, however, after the transient expression de-
cayed, none of the samples could be clearly distinguished from the
dCas9 controls representing random integration (Supplementary Fig.
S2A).
Since we expected linearized plasmids to be more readily inte-
grated, next, we linearized the GFP-plasmid with a restriction en-
zyme and tested its integration similarly in N2a cells, and also, with
an overlapping set of gRNAs in NIH/3T3 mouse fibroblast cells.
Since the linearized DNA is more vulnerable to cellular nucleases, in
order to decrease the possibility of digestion of the expression cas-
sette before the targeted integration would take place, more than
1000 bp-long extra sequences were left at both sides of the GFP ex-
pression cassette when linearized by the restriction enzyme. The use
of a linearized plasmid resulted in higher integrations in both cell
lines (Supplementary Fig. S2B and C), however, similarly to the pre-
vious results using circular plasmid (Supplementary Fig. S2A), none
of the samples provided signals over twice as large as the level of ran-
dom integrations. This is in spite of that the majority of the employed
gRNAs supported HR mediated targeted integration in N2a cells
(unpublished results). These data, in line with the general perception,
suggest that the efficiencies of capturing circular or pre-linearized ex-
ogenous DNA by NHEJ-repair at the sites of targeted cleavage are
not generally sufficient to be clearly detectable above the level of ran-
dom integration.
The efficiency of targeted integration of exogenous DNA by
NHEJ was reported to be somewhat higher when the donor plasmid
was linearized inside the cell by designer nucleases.38,44,52 To exploit
this possibility, we picked two efficient-gRNA expressing plasmids
that were available in our laboratory (targeting Ttn and Rbl2 gen-
es—referred to as Ttn and Rb, respectively), and cloned each corre-
sponding protospacer into the GFP-plasmid either preceding, or both
preceding and following the GFP-cassette (Fig. 1A). These plasmids
and the control (protospacerless) GFP-plasmid were each co-
transfected with a vector containing an active SpCas9 and the corre-
sponding gRNA (Rb or Ttn) or a vector containing inactive SpCas9.
The numbers of fluorescent cells were counted as previously. The in-
cell cleavage of plasmids resulted targeted integrations four to six-
fold above the background level of random integration measured
with circular, protospacerless GFP-plasmid and active SpCas9
(Fig. 1B).
The difference was less than two-fold between the two controls,
when cleaving the genome without in-cell linearization and the ran-
dom integration of a circular GFP-plasmid (Fig. 1B), similarly as we
Figure 1. in-cell cleavage of the GFP-plasmid facilitates targeted integration.
(A) Scheme of the genomic integration of an in-cell cleavable plasmid. The
target sequence of the gRNA (magenta) from the plasmid containing the
SpCas9 is present both in the genome (magenta target in the grey double
helix) and in the GFP-cassette containing plasmid - either preceding or at
both ends (the latter case is shown in the figure by two magenta boxes) of
the GFP-cassette (green). SpCas9 cleaves both the genome and the GFP-
plasmid. During repair of the broken genomic DNA, the opened plasmid will
efficiently integrate into the genome at the cleavage site even in the absence
of homologous arms. The protospacer on the GFP-plasmid has to be rede-
signed and re-cloned for every new genomic target in order to achieve open-
ing of the plasmid. (B) in-cell linearization of the circular plasmid increases
the efficiency of the genomic integration. Two different genes, Rbl2 and Ttn
were chosen and targeted by corresponding gRNAs (Rb and Ttn, respec-
tively), to test the effect of in-cell linearization of the GFP-plasmid. Bars show
the percentages of cells harbouring stably integrated GFP-cassette after co-
transfection by an expression vector for both SpCas9 and either Rb or Ttn
gRNAs and a circular GFP-plasmid that either contains one (Rb 1x, Ttn 1x) or
- as on scheme A - two (Rb 2x, Ttn 2x) copies of the respective targets (light
grey bars). As controls (dark grey bars), an inactive SpCas9 with the GFP
plasmid (dead) and to measure the backgrounds without in-cell cleavage, an
active SpCas9 with Rb or Ttn targets combined with the circular plasmids
were used (Rb -, Ttn -). The values were compared to their respective circular
control with the active nuclease. Bars show the means6 S.D. of percentages
measured in n ¼ 3 independent transfections, which were normalized to the
transfection efficiency (% GFP positive cells measured on 2nd day after
transfection: ranging between 87 and 91%). ***P<0.001.
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found earlier using different spacers (Supplementary Fig. S2A).
Cleaving at both sides of the GFP-cassette may lead to more in-cell
linearized plasmids, and so it may be expected to result in higher in-
tegrations. However, we detected no increased fluorescence with the
plasmids that contain two targets thus, for the further experiments
we cleaved only at one site of the plasmids.
3.2. Construction of self-cleaving plasmids with
universal target-spacer pairs
Although the above results are encouraging and indicate that the in-
tegration of in-cell linearized plasmids without homology arms are
effective in these cells, such a design does not allow the measurement
of the actual integration to the SpCas9 cleaved genomic sites. This is
because the same gRNA mediates the cleavage of the genome and of
the plasmid, and thus, the two events are coupled and it is not possi-
ble to assess the background originating only from the random inte-
gration of the in-cell linearized plasmid independently of the genome
cleavage.
Furthermore, the efficiency of targeted integration when using the
same target sequence both in the genome and in the GFP-plasmid
(Fig. 1A) depends on both, possibly differing, effectiveness of cleav-
ing the target in its genomic context and out of its genomic context
on the GFP-plasmid. To allow a more comparable and adequate esti-
mation of cleavage activities for various gRNAs on their targets in
their genomic context, the use of one common GFP-plasmid that
contains the same target sequence ensuring identical in-cell cleavage
for all gRNAs to be tested, and which is also independent of the
tested targets, would be the most adequate. In addition, such an ap-
proach would eliminate the need for the laborious cloning of each
corresponding protospacer to the GFP-plasmid for each spacer to be
tested. The practicality of such generally applicable plasmid would
be further extended if the corresponding common gRNA for the in-
cell cleavage of the plasmid was also placed into the GFP-plasmid.
Further we refer to plasmids constructed in this way as ‘self-cleav-
ing’, since such plasmids, expressing the gRNA with its own target,
are programmed to initiate their own cleavage (Fig. 2A).
To prepare such effective GFP-plasmids for general use, we
computer-generated a pool of 30,000 random spacer sequences and
picked the ones that have the least predicted off-targets in the mouse
genome as assessed by e-CRISP Cas9 construct designer53 and had
the best predicted efficiency by sgRNA Designer.16,21 From these,
two candidates were picked that according to the CasFinder54 have
no targets in the human genome and in 11 frequently employed
model organisms (mouse, rat, cat, dog, pig, cow, chicken, zebrafish,
C. elegans, Drosophila, and S. cerevisiae) thus, reserving the poten-
tial to be used more generally for self-cleaving GFP-plasmids in dif-
ferent cell lines/organisms (although, we do not explore these
possibilities here). We refer to these as TL (targetless) spacers, TL1
and TL2; these two spacer sequences were used to generate two ‘self-
cleaving’ GFP-plasmids (referred to as pSc1 and pSc2, respectively -
Addgene #80436, #80437) containing both the TL spacer/gRNA
and the corresponding protospacer on one vector (Fig. 2A).
We tested the targeted integration of the two self-cleaving plas-
mids in combination with either the Ttn or Rb-gRNA in comparison
with the Ttn and Rb cleaved in-cell linearized plasmid (Fig. 2B, indi-
cated as Rb-, Ttn-InCell), as earlier. As a control, TL-gRNA bearing
plasmids were co-transfected with either of the two self-cleaving plas-
mids; thus, the GFP-plasmid is linearized in-cell without the genome
being targeted. These experiments demonstrate that the self-cleaving
plasmids achieve comparable integrations with the two in-cell
Figure 2. (A) Scheme of the genomic integration of a self-cleaving plasmid.
The target sequence of the gRNA (magenta) expressed from the SpCas9 plas-
mid is present only in the genome (magenta target in the grey double helix).
The circular plasmid that contains a GFP-box (green) harbours a genomic-tar-
getless gRNA (TL gRNA) and its target sequence (blue boxes). During repair of
the broken genomic DNA, the opened plasmid will efficiently integrate into the
genome at the cleavage site even in the absence of homologous arms. Such
construction of the GFP-plasmid does not require retailoring the protospacer
for every new genomic target and can be universally used. (B) The efficiency of
targeted integration when using self-cleaving GFP-plasmid in N2a cells. The
percentages of the cells harbouring a stably integrated GFP-cassette are
shown. The Rbl2 or Ttn genes were targeted by the corresponding gRNAs, Rb
or Ttn, respectively. Cells were co-transfected by the expression vector for
both wild type SpCas9 and a respective gRNA, and either of the self-cleaving
circular GFP-plasmids pSc1 or pSc2 or the circular GFP-plasmid containing the
Rb or Ttn protospacer (Rb-InCell, Ttn-InCell) or without containing any target
sequence (Rb or Ttn, Circ). To measure the random integration background of
the self-cleaving plasmids, they were co-transfected with a vector expressing
active SpCas9 and the corresponding TL gRNAs; thus, the genome is not tar-
geted, but the self-cleaving plasmids are linearized (TL1, TL2). As an additional
negative control, an inactive SpCas9 was used along with either of the two
self-cleaving plasmids (dead). Bars show the means 6 S.D. of percentages
measured in n ¼ 3 independent transfections, which were normalized to the
transfection efficiency (% GFP positive cells measured on 2nd day after trans-
fection: ranging between 94 and 96%).
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cleaved GFP-plasmids in case of both genome-targeting (Ttn or Rb)
gRNAs tested. This suggests that both gRNAs containing TL spacers
(TL-gRNAs) support as efficient plasmid DNA cleavage as the Rb or
Ttn spacers do. Thus, these self-cleaving plasmids seem to facilitate
efficient integration, while providing a more adequate assessment of
efficiencies of different gRNAs.
The two self-cleaving GFP-plasmids pSc1 and pSc2 were further
used to test 11 spacers, targeting 7 different mouse genes [Pten,55
Rbl2, Tp53,55 Prnp, Sprn, Piwil2, and Piwil4 (Fig. 3A and B)].
Targeted integration is assessed here as the fluorescence above the
background level that derives from the random integration of the in-
cell cleaved self-cleaving plasmid. For this control sample the gRNA,
which is identical to the corresponding TL-gRNA of the self-cleaving
plasmid is placed to the SpCas9 plasmid; thus, the GFP-plasmid is
linearized in-cell without the genome being targeted. The random in-
tegration of these in-cell-cleaved GFP cassettes is usually about 4–
5%, which is higher than the random integration of a circular (1–
2%) or even a linear (2–3.5%) plasmid. The nearly 2% increment
likely come from an increased propensity of the in-cell cleaved plas-
mid for random integration, although a contribution also from off-
target cleavage activity of the TL guides cannot be ruled out.
Nevertheless, these values—although, may vary among cell types—
are sufficiently low to allow the detection of targeted integration
above this background level fluorescence.
Several spacers gave rise to targeted integration (above the ran-
dom levels of 4%) in combination with either of the two self-cleaving
plasmids, pSc1, or pSc2 (Fig. 3A or 3B, respectively). Experiments
with the least effective spacer piwi2, (indicated as ‘piwi2’, Fig. 3) re-
sulted in no clearly detectable targeted integrations that would ex-
ceed random integration of an in-cell cleaved plasmid. By contrast,
the pten spacer (indicated as ‘pten’, Fig. 3) was by far the most effec-
tive with both self-cleaving plasmids mediating targeted integration
of around 25%. The two self-cleaving GFP-plasmids supported tar-
geted integrations in a similar fashion in combination with the 11
spacers. To test the presence of targeted integrations, we performed
PCR using one primer complementary to the end of the plasmid and
another one complementary to the genomic locus, on DNA samples
purified from the stably transfected cell populations. Testing on the
Pten locus agarose gel electrophoresis analysis revealed that the plas-
mids were incorporated at both orientations to the target site
(Supplementary Fig. S3). Direct sequencing of the PCR products in
case of integration at a different locus (Tp53), demonstrated that a
considerable fraction of the integrations took place by error-free
NHEJ repair (Supplementary Fig. S4) as it had also been reported
earlier for blunt ended NHEJ-cloning.38,46
In another experiment, additional seven gRNAs (targeting the
mouse Vim and Dcun1d2 genes) were tested along with those target-
ing Pten, Rbl2, and Ttn, with both the wild type and the enhanced
SpCas9 (eSpCas9) (Supplementary Fig. S5). While for Rb and Ttn
both nucleases showed comparable efficiencies and for four other
gRNAs (all that target Dcun1d2 and with vim1 spacer) neither of the
nucleases showed efficient cleavage compared to their controls, with
another four wtSpCas9 produced higher rates of targeted integra-
tions while eSpCas9 showed low or no activity, which most probably
is attributable in part to the higher specificity of eSpCas9.
3.3. The universal self-cleaving GFP-plasmid approach
compares to an HR-based fluorescence reporter
method and it is also effective in NIH/3T3, HeLa, and
HEK293 cells
We compared the relative efficiencies of four prion protein gene-
targeting spacers to result either HR or NHEJ mediated targeted inte-
gration of a GFP-cassette flanked by either 1 kb-long homology arms
or no homologous sequences, respectively. The latter is present in the
pSc1 plasmid (Fig. 4). We selected genomic targets whose cleavage
sites are situated within a few base pairs in order to minimize the effect
of the distances between cleavage sites of SpCas9 and the beginning of
the homologous region, on the efficiency of HR-mediated targeted in-
tegration. Two of the cleavage sites (prp2, prp3) were situated in a few
nucleotide distances from the end of the upstream and two other
(prp4, prp5) from the beginning of the downstream HR arms, respec-
tively. Both HR and NHEJ mediated integrations indicated that both
target pairs can be efficiently cleaved by SpCas9. Interestingly, in case
of the upstream site gRNAs (prp2 and -3) prp2 seems to be more effec-
tive than prp3 when assessed by NHEJ-mediated integration that is
not apparent in the HR-mediated assay.
In another experiment, we selected and cloned 5 spacers targeting
the Rosa26 locus in the mouse genome (one of them, rosa5 spacer
Figure 3. The efficiency of different spacers to mediate targeted integration
when used with self-cleaving GFP-plasmids in N2a cells. The efficiencies of
different spacers in targeted integration using the pSc1 (A) or pSc2 (B) self-
cleaving GFP-plasmid are assessed. The percentages of the cells harbouring
stably integrated GFP-cassette were measured for 11 different spacers (pten,
Rb, p53, prp1-5, sho, piwi1-2) targeting seven genes (Pten, Rbl2, Tp53, Prnp,
Sprn, Piwil4, Piwil2) as indicated by the light grey bars, when co-transfecting
with either the circular pSc1 (A) or pSc2 (B) self-cleaving GFP-plasmids. To
measure the random integration background of the self-cleaving plasmids,
they were co-transfected with a vector expressing active SpCas9 and the cor-
responding TL gRNA; thus, the genome is not targeted, but the self-cleaving
plasmids are linearized (genome not targeted, Sc1 in-cell cleaved; A and B,
indicated by the dashed lines). Bars show the means 6 S.D. of percentages
measured in n ¼ 3 independent transfections, which were normalized to the
transfection efficiency (% GFP positive cells measured on 2nd day after
transfection: ranging between 94 and 98%). Values obtained are compared
to the control where the linearized self-cleaving GFP-plasmid (genome not
targeted, pSc1 in-cell cleaved) was used. ***P<0.001.
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previously reported in ref.56). The five gRNAs seem to mediate com-
parable cleavage efficiencies (about 10–20%) by both approaches
(Supplementary Fig. S6), although the target sites were not so care-
fully selected as in case of Figure 4 and thus, the relative position of
the targets may have influenced their efficiency in the HR-mediated
assay.
HR-mediated integration is currently the only approach used in
fluorescence-based methods that are capable of testing the genomic
targets in their genomic context (GFP-disruption and analogous as-
says are restricted to targets aimed at the GFP sequences). However,
the HR-mediated method is much more laborious due to the need to
construct the homologous arms. Therefore, it is only worth to apply
it for screening gRNA-efficiencies if the eventual application is to em-
ploy the same homologous arms. Thus, the advantages of our ap-
proach over other fluorescence-based methods for gRNA testing are
apparent and it may be more relevant to compare to PCR-based
methods what we present later in the manuscript.
Further experimentation on NIH/3T3 mouse fibroblast cells with
one of the self-cleaving plasmids and seven spacers of the set previ-
ously tested in N2a cells, targeting five genes (Pten, Rbl2, Tp53,
Prnp, and Piwil4) resulted in sufficiently high targeted integrations
(i.e. for the majority of the spacers clearly measurable above the
background 5%) (Supplementary Fig. S7A). The most effective
spacer, pten resulted in close to 15% targeted integration, whereas
piwi2 showed no detectable targeted integration. Thus, these results
recapitulate those seen earlier with these spacers in N2a cells and
suggest that our approach is applicable in NIH/3T3 mouse cells as
well.
The TL spacers have neither targets nor predicted off-targets in
the human genome, allowing us therefore, to test the applicability of
our approach on human cells as well. The commonly used human
cell line HeLa was selected, using one of the two self-cleaving plas-
mids (pSc1). We could not use most of the mouse gene-targeting
spacers tested earlier in N2a cells on the corresponding human geno-
mic sites; however, we recognized that the pten spacer also targets
the human PTEN gene and PTENP1 pseudogene. In addition, two
other spacers that target the human PRNP gene were designed.
While the in-cell linearized plasmid background remained at 1.4%,
the two prion protein targeting spacers and the pten spacer mediate
targeted integrations (i.e. above background level) from 5% to 15%,
respectively (Supplementary Fig. S7B). Additionally, four previously
reported active gRNAs57 were tested in HEK293 cells targeting the
LMNA and PML genes along with the gRNA targeting the PTEN
gene. All spacers mediated effective targeted integrations
(Supplementary Fig. S7C). Altogether, these results on different cell
lines (N2a, NIH/3T3, HeLa, and HEK293) suggest that NHEJ-
mediated targeted integration in combination with these self-cleaving
plasmids is sufficiently high above random integration to exploit it
for testing gRNA efficiency more generally.
3.4. Shortening detection time with a degradation
domain fused to GFP
Although these experiments demonstrate the effectiveness of our ap-
proach requiring little effort and cost, the long time-frame necessary
for obtaining the readout limits its use. Our experiments suggested
that the long decay time of the transient signal originates from the
high stability of GFP protein molecules that are present after the dis-
appearance of the plasmid DNA. To avoid this effect, ideally, GFP
expression should be induced after the degradation of the transfected
plasmid DNA in the cell, ensuring that the GFP expression originates
only from the integrated copies of the expression cassette. We
achieved a similar outcome by fusing a degradation domain (DD), a
destabilized mutant of E. coli dihydrofolate reductase (ecDHFR)
protein to GFP that drives faster degradation of the fluorescent pro-
tein. The degradation domain is stabilized in the presence of trimeth-
oprim (TMP), preventing enhanced degradation.50 Adding TMP to
the cells after the transfected plasmid DNA has disappeared allows
the detection of the GFP signal originating only from proteins ex-
pressed from the integrated copies.
Fusing the degradation domain either to the N- or to the C- termi-
nus of GFP resulted similar expression profiles (data not shown),
thus, we selected the N-terminal fusion for further experiments and
placed it to a self-cleaving plasmid (pSc1-DD, Addgene #80439).
Three gRNAs tested previously, Rb, p53, and piwi2 (the first two
representing efficient, whereas the third poor gRNAs) were exploited
to adjust the condition of the modified assay employing pSc1-DD.
The gRNA-Cas9 plasmids were co-transfected with both the pSc1-
DD plasmid and an mCherry coding plasmid to N2a cells. The latter
allows for monitoring the transfection efficiencies. To determine the
earliest time point that is appropriate for distinguishing between
poor and active gRNA-s, GFP positive cells were measured daily
from the 2nd to the 10th day post transfection (data not shown).
TMP was added to all samples 24 h before FACS analysis. The
gRNAs tested previously with the pSc1 and pSc2 plasmids (Fig. 3),
now with pSc1-DD showed similar activities. This approach resulted
in the successful reduction of the assay time from 12–15 to 6–8 days
Figure 4. Efficiency of integration of the self-cleaving plasmid to the genome
is comparable to that of a HR-mediated integration. The percentages of the
cells harbouring a stably integrated GFP-cassette (without normalization to
the transfection efficiency) are shown for four different spacers targeting the
Prnp gene (prp2-5). Cells were co-transfected by an active SpCas9 and the re-
spective gRNA expressing vector along with either of the following GFP-
plasmids: a homologous recombination (HR) donor GFP-plasmid (empty
bars) containing a promoter-less GFP gene with 1 kb homologous arms for
the Prnp gene at both sides of the GFP-cassette; or the self-cleaving GFP-
plasmid pSc1 (grey bars). As a control for the HR mediated integrations, the
HR donor plasmid was co-transfected with an inactive SpCas9 expression
vector (dead Cas9). The values obtained for this control (0.1%) indicated as
random integration background with HR, was subtracted from all corre-
sponding sample values to determine the extent of targeted integrations.
For experiments with the self-cleaving plasmid, the control used was the
self-cleaving plasmid pSc1 co-transfected with a vector expressing active
SpCas9 and the TL1 gRNA and thus, the pSc1 plasmid is linearized in-cell
but the genome is not targeted (indicated as random integration background
with pSc1 donor). The value obtained for this control (5%) was subtracted
from all corresponding sample values to determine the extent of net tar-
geted integrations. Values were not normalized for transfection efficiency in
either experiments. Bars show the means 6 S.D. of percentages measured
in n ¼ 3 independent transfections.
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(Fig. 5). The activities of the gRNAs are clearly distinct (i.e. the poor
and good gRNAs can be easily distinguished) on the 6th day post
transfection, although the fluorescence stabilizes only from the 8th
day (data not shown).
3.5. The approach is also validated by two PCR-based
methods: TIDE and T7 endonuclease I assay
Ten spacer sequences targeting six genes in the mouse genome (four
for Prnp, two for Pten, and one for Dcun1d2, Rbl2, Tp53, and
Piwil4 genes), were selected for a comparison of this approach and
indel detection methods such as Tracking Indels by Decomposition
(TIDE33) and T7 endonuclease I assay. These 10 gRNA-Cas9 plas-
mids were used for co-transfection with the pSc1-DD plasmid into
N2a cells. Genomic DNA from the FACS-analysed cells was ex-
tracted on the 8th day post transfection and the SpCas9 targeted sites
were PCR amplified and indels were detected by both TIDE and T7
endonuclease I assay. All approaches, this reporter assay, TIDE and
T7 endonuclease I assay identified the same five gRNAs as being the
more efficient ones (pten, pten2, p53, Rb, and prp2) and the same
five gRNAs to result low or no cleavage activities (prp8, prp9,
prp10, piwi2, and dcun1d2) (Fig. 6). However, as expected, the rela-
tive efficiencies among the gRNAs slightly differed, likely reflecting
the differences in the outcomes of the competing repair events they
monitor.
3.6. In-cell cleavage of a linear plasmid does not
recapitulate the same level of integration as in-cell
cleavage of a circular plasmid
It is not clear why in-cell cleavage of circular plasmids promotes
more efficient integration as compared to transfection of linear,
i.e.: out-of-cell cleaved ones (we refer to this as pre-linearized plas-
mids). One explanation could be that linear DNA is more prone to
degradation and a large proportion of the transfected DNA is di-
gested before its targeted integration can take place. Alternatively,
the end of the linear molecule might become integration incompetent
with time, for example by concatemerization. It is also possible that
NHEJ ligation may preferentially take place among DNA ends that
are liberated at the same time. To get more insight into this problem
we compared NHEJ-mediated targeted integration of pre-linearized
plasmids either cleaving or not cleaving them again in-cell. in-cell
cleavage of the pre-linearized plasmids apparently does not increase
targeted integration whereas in-cell linearization of the circular plas-
mid (resulting in one fragment) facilitated twice as many targeted in-
tegrations as pre-linearization (Fig. 7).
Since in-cell double cleavage (where the restriction enzyme linear-
ized plasmid is cleaved both upstream and downstream the GFP-
cassette), may effectively triple the number of DNA molecules with
free ends, it might adversely affect the integration efficiency of the
fragment containing the GFP-cassette having to compete for the
available genomic DNA breaks. To account for this effect, we re-
peated the experiments, now using controls of pre-linearized plas-
mids digested into one, two or three pieces. The linear plasmids were
also cleaved again once or twice in-cell generating either two or three
fragments, respectively (Supplementary Fig. S9). Pre-linearization of
the plasmids into two or three pieces before transfection decreased
targeted integration, as expected. in-cell cleavage of the pre-
linearized plasmid into two or three pieces facilitated targeted
Figure 5. Shortening detection time with a degradation domain fused to
GFP. The percentages of the cells harbouring stably integrated GFP-cassette
were measured between 6 and 8 days after transfection when a self-cleaving
plasmid with a degradation domain-fused GFP (pSc1-DD) was co-transfected
with three formerly used (e.g. Fig. 3) SpCas9-gRNA coding plasmids (target-
ing the Rbl2, Tp53 and Piwil4 genes) and an mCherry coding plasmid (to
track transfection efficiency) to N2a cells. To stabilize the degradation do-
main, trimethoprim was added to the cells 24h before FACS analysis. As
controls, the pSc1-DD plasmid was co-transfected with either (I) a nuclease
inactive SpCas9 coding plasmid (dead); or (II) with an active SpCas9 and the
TL1 gRNA expressing vector and thus, the pSc1 plasmid is linearized in-cell
but the genome is not targeted (indicated as genome not targeted pSc1-DD
in cell cut). Bars show the means 6 S.D. of percentages measured in n ¼ 3
independent transfections, which were normalized to the transfection effi-
ciency [% mCherry positive cells (ranging between 44 and 52%) measured
on the 2nd day after transfection].
Figure 6. Validation of the method by TIDE and T7 endonuclease I assay. The
activities of 10 gRNA-s are shown that were measured with the degradation
domain-fused GFP bearing self-cleaving plasmid (pSc1-DD, dark grey boxes)
and with indels that were detected in the same samples with TIDE (light grey
boxes) and T7 endonuclease I assay (medium grey boxes). The percentages
of the cells harbouring a stably integrated GFP-cassette are shown for 10 dif-
ferent spacers targeting the (Prnp, Pten, Dcun1d2, Rbl2, Tp53, and Piwil4
genes). Cells were co-transfected by an active SpCas9 and the respective
gRNA expressing vector along with the degradation domain bearing GFP-
self-cleaving plasmid, pSc1-DD (dark grey bars). As a control the pSc1-DD
was co-transfected with an active SpCas9 and the TL1 gRNA expressing vec-
tor and thus, the pSc1-DD plasmid is linearized in-cell but the genome is not
targeted (indicated as genome not targeted, pSc1-DD in-cell cut). The GFP
positive cells were analysed by FACS 8 days after transfection. Bars show
the means 6 S.D. of percentages measured in n ¼ 3 independent transfec-
tions which were normalized to the transfection efficiency [% mCherry posi-
tive cells (ranging between 44 and 52%) measured on the 2nd day after
transfection]. After FACS measurements, the three parallel samples were
mixed, genomic DNA was isolated and three parallel PCR reactions were car-
ried out from each sample. Indels were measured by both TIDE and T7 endo-
nuclease I assay on each PCR reaction. The agarose gel electrophoresis
analysis of T7EI assays are shown in Supplementary Fig. S8.
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integration twice as much as pre-linearization of the plasmids into
two or three pieces before transfection. However, no significant dif-
ferences were seen when the pre-linearized plasmid was cut once or
twice in-cell (Supplementary Fig. S9). Thus, in-cell cleavage of pre-
linearized plasmid failed to increase targeted integration to a similar
level as the in-cell cleavage of a circular DNA. These experiments
suggest that the major reason for the increased targeted integration
of in-cell cleaved circular plasmids in N2a cells is the higher resis-
tance to nucleases, although these experiments do not rule out a posi-
tive contribution from a synchronized in-cell cleavage.
3.7. NHEJ-cloning employing SpCas9 and a self-
cleaving plasmid is superior to random integration
Targeted integration of plasmids as large as 5 kb by NHEJ-cloning
using SpCas9, had also been demonstrated in mammalian cells, al-
though, with limited efficiency.45 We used a self-cleaving plasmid to
assess if NHEJ-cloning is capable of targeted integration of 10 kb
plasmids with sufficient efficiency. A 5 kb cassette was cloned to the
self-cleaving plasmid (resulting in 10805 bp final size) and its integra-
tion was tested with the most effective spacer (pten) used in these
studies. We found 30% and 18% targeted integration (without nor-
malization for the transfection efficiency i.e.: without upscaling to
100%) of the 10 kb plasmid harbouring a GFP-cassette in N2a and
HeLa cells, respectively (Supplementary Fig. S10A and B). These ex-
periments suggest that the size of the plasmid in this range is not a
limiting factor for NHEJ-cloning in these cell lines.
The efficiencies we achieved here for targeted integrations are al-
most an order of magnitude higher than those reported earlier in
HEK293 cells without using a self-cleaving plasmid.45 To see if the
differences are attributable only to the different cell lines (N2a, NIH/
3T3, HeLa vs. HEK293, and CHO) used, we tested our approach on
HEK293 cells as well. The experiments presented on Supplementary
Fig. S10C demonstrate that by using self-cleaving plasmids (either 5
or 10 kb large), efficient integrations are achievable in HEK293 cells,
showing more than an order of magnitude higher efficiencies than
seen in earlier studies [7% targeted integration here (Supplementary
Fig. S10C) vs. 0.17% in Ref. 45]. These results were confirmed later
exploiting more targets (Supplementary Fig. S7C).
Our experiments suggest that NHEJ-cloning using SpCas9 nucle-
ase with a self-cleaving plasmid could be a superior alternative to
random integration of DNA cassettes. To establish an easy way for
integration of DNA cassettes to safe-harbour locations, we identified
5 spacers targeting the Rosa26 locus in the mouse genome, as dis-
cussed earlier (Supplementary Fig. S6).
We also examined whether NHEJ-cloning of a self-cleaving plas-
mid would result in coupled integration of two expression cassettes
harboured on the same plasmid. This is a major concern exploiting
random integration where selection for an antibiotic does not always
result in expression of the target gene located on the same plasmid.
N2a cells were co-transfected with two plasmids: one is a self-cleav-
ing plasmid containing both a GFP and a puromycin expression cas-
sette (pSc1-puro, Addgene #80438) and the other is a plasmid for
SpCas9 and gRNA expression targeting the PTEN gene. The fraction
of cells exhibiting GFP fluorescence was counted by FACS after 10
days of puromycin selection when the transient GFP expression had
been decayed. These experiments demonstrated about 90% coupled
integration of the puromycin and the GFP expression cassettes by
NHEJ-cloning of a self-cleaving plasmid. By contrast, this value is
50% for coupled random integration in the same experimental setup
but without cleaving the plasmid and the genome (Supplementary
Fig. S11). This latter experiment resulted in two orders of magnitude
less resistant cells indicating the higher efficiency of NHEJ-cloning.
4. Discussion
In the absence of accurate prediction tools for the efficiency of Cas9
spacers, suitable gRNAs can only be selected reliably by experimen-
tal testing. Although several approaches exist to measure the activity
of SpCas9-gRNAs,24 there is an absence of simple fluorescence-
based methods that would be able to assess the effectivity of gRNAs
on targets in their genomic context while ensuring an easy and reli-
able detection by FACS. Here, we introduced a method that fulfils
this gap and offers a simple alternative to existing approaches for
testing gRNA efficiencies prior to executing more complex applica-
tions like generating specifically modified cell lines, transgenic ani-
mals or performing multiplex genome engineering tasks. As it
requires only the ready gRNAs, our method can be applied by simply
co-transfecting the Cas9-gRNA plasmids with a self-cleaving repor-
ter plasmid. Thus, it does not require extra cloning steps for testing a
particular gRNA in contrast to other fluorescent reporter-based
methods.35,39,40,42 In Table 1, we compared the self-cleaving plasmid
reporter method to other FACS- and PCR-based methods. Although,
the exact numbers for some of the parameters may vary from lab-to-
lab making an absolute comparison difficult, considering optimal in-
stances for each, the self-cleaving method presents numerous advan-
tages over the other methods. FACS-based methods are inherently
Figure 7. Integration efficiency of the in-cell cleaved pre-linearized plasmid is
lower than that of the in-cell cleaved circular plasmid in N2a cells. The per-
centages of the cells harbouring stably integrated GFP-cassette are shown
when targeting two different genes, Ttn or Rbl2 with the spacers Ttn or Rb,
respectively, as indicated. In case of either of the targets, the cells were co-
transfected by an expression vector for nuclease active SpCas9 (þ) and the
respective gRNA (Rb or Ttn) along with: (I) a circular GFP-plasmid containing
two matching protospacers (þþ) before and after the GFP-cassette (dark
green bars; as seen formerly in Fig. 1A); (II) a pre-linearized GFP-plasmid
containing two matching protospacers (þþ) before and after the GFP-cas-
sette (light green bars); (III) a pre-linearized GFP-plasmid containing no pro-
tospacers (magenta bars). For both spacers as a negative control a nuclease
inactive SpCas9 (-) and gRNA expressing plasmid was co-transfected with a
pre-linearized GFP-plasmid (grey bars). For the in-cell linearized plasmid, as
a control, a circular plasmid with no matching protospacer was co-trans-
fected with Rb spacer and SpCas9 expressing vector, therefore, the plasmid
cannot be linearized in the cell (sky blue bar). As an additional control a cir-
cular GFP-plasmid was co-transfected with inactive SpCas9 nuclease ex-
pressing vector (orange). Bars show the mean 6 standard deviation (S.D.) of
percentages measured in n ¼ 3 independent transfections which were nor-
malized to the transfection efficiency (% GFP positive cells measured on 2nd
day after transfection: ranging between 95 and 99%).
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less labor-consuming than PCR based methods. As far as optimiza-
tion is concerned, here only a new cell line may present a need for op-
timization, which for our technique refers to adjusting the
parameters of a FACS device. However, if the transfection efficiency
is also measured when a PCR-based approach is applied (generally
and most easily by exploiting a fluorescent protein and FACS), no
extra optimization is necessary, in this sense, for our method. By con-
trast, PCR-based approaches require some optimization of the pri-
mers and PCR condition for each target region selected. Thus, it
seems to be a favourable alternative approach for those who do not
mind the longer time-frame in exchange for spending less effort on
gRNA testing.
Another built-in advantage of the method is that the transfection
efficiencies can easily be determined by simply measuring the GFP
fluorescence of a portion of each population on the second day post
transfection. While the transfection efficiency influences the readout
of any gRNA-testing method to a great extent, it is generally not
monitored in most of the studies using either PCR- or fluorescence-
based methods.58,59
The targeted integration of the GFP-cassette can be assessed only
after the transient expression has decayed. The use of an inducible
degradation domain fused to GFP decreased this time to 6–8 days, a
time-period that is less than what is usually needed for deep sequenc-
ing, but it is slightly longer than that required for measuring indel
frequency by Surveyor/T7E1 assay (Table 1).24 The extent of the ran-
dom integration also seems to vary with the condition of the cells;
this makes necessary the use of appropriate negative controls such as
non-targeted integration of the in-cell cleaved plasmid, in each
experiment.
The method measures the targeted integration to sites of genomic
cleavage identified by the gRNA. Thus, it does not distinguish be-
tween on-target and off-target cleavage. However, off-target cleavage
can generally be kept low with the careful design of the spacer se-
quence and using improved SpCas9 nucleases with reduced off-
target effect, such as eSpCas9 (Supplementary Fig. S5) or SpCas9-
HF.60,61
The extent and nature of the correlation between generating dou-
ble strand breaks and integrating exogenous DNA by NHEJ repair is
difficult to assess since there is no easily available method to directly
measure the formation of double strand breaks in the cells. Most
approaches are based on detecting those outcomes of the repairs of
double strand DNA breaks that result in altered sequences.24
However, the exact correlation between the number of double strand
breaks and detectable repair events (i.e. repairs resulting in altered
sequences) are not known for any of the approaches designed to
monitor it. As such, they depend on many factors, for instance, the
actual DNA sequence at the break and the position and presence of
microhomologies that are thought to greatly influence the ratio of
error-free to non-error-free NHEJ repair.62–64 The conditions and
factors that influence the ratio of HR to NHEJ mediated repair are
also difficult to account for.25 In addition, both main repair systems
are capable of capturing foreign DNA at the break points, although
the factors that may influence this are also poorly understood, for in-
stance the ratio of NHEJ-mediated integration and indel generating
NHEJ repair. In addition, the actual methods used might not accu-
rately measure the frequency of mutations generated by the repair
system. For example, it is not fully understood how the distribution
and nature of the mutations in the indel population affect the out-
come of the Surveyor/T7E1 nucleases assays.65,66 Furthermore,
PCR-based methods generally ignore larger deletions or insertions of
which frequencies might also influence the number of smaller indels
detected.24 Thus, it is not apparent that the relative efficiencies of
spacers would be identical when assessed with two different meth-
ods. Nevertheless, all approaches are likely to be suitable for a rough
estimation to distinguish very poor from efficient spacers.
Here, we measured NHEJ mediated and HR mediated targeted in-
tegration using the same sets of gRNAs (Fig. 4, Supplementary Fig.
S6). The gRNAs were designed to minimize the positional effects of
the target position in relation to the homologous arms. Although
there might be several other factors difficult to account for, this al-
lowed a more direct comparison of the gRNA efficiencies to induce
DNA repair by the two repair systems. The method was also com-
pared to both TIDE and T7 endonuclease I assays that measure indel
frequencies induced by SpCas9 cleavage employing an identical set
of gRNAs. These experiments confirmed that our approach is capa-
ble of distinguishing poor and efficient spacer sequences and is a use-
ful, effortless alternative for screening for more efficient gRNAs.
The method absolutely requires in-cell cleavage of the GFP-
plasmid to be integrated. Occasionally, we were able to detect tar-
geted integration of pre-linearized plasmids above the background
random integration with some spacers (Fig. 7); however, these were
neither reproducible nor robust enough to base a method on. The
underlying exact mechanism for the integration of the in-cell cleaved
plasmids is not well understood. To distinguish between alternative
scenarios, we in-cell re-cleaved the pre-linearized plasmid (Fig. 7,
Supplementary Fig. S9). These experiments seem to indicate that the
major factor for the difference is that circular DNAs are more resis-
tant to cellular DNases than the linear ones are. However, it is still
Table 1. Comparison of methods that can detect Cas9 nuclease induced DNA mutations
PCR based methods FACS-based assays
TIDE33 T7E1 NGS GFP disruption EGxxFP40 self-cleaving plasmid
Readout time 2–5 days 2–3 days 7–21 days 3–7 days 2 days 6–8 days
Hands-on time/sample 3 h 3 h 3 h 40 min 30 min 40 min
Optimization needed Yes Yes Yes No No No
Genomic context Yes Yes Yes Yes No Yes
Any target Yes Yes Yes GFP targets only Yes Yes
Extra cloning steps No No No No Yes No
Cost/sample $25 $18 $70 $7 $6 $7
The self-cleaving plasmid method is compared to some of the PCR- and FACS-based assays’ most relevant attributes, which can detect Cas9 nuclease induced
mutations. The cost and time calculations are available in detail in Supplementary Data. Favourable conditions are marked with white and less favourable condi-
tions are marked with grey backgrounds.
618 A self-cleaving GFP-plasmid method to pre-screen gRNAs
Downloaded from https://academic.oup.com/dnaresearch/article-abstract/24/6/609/3904549
by Hungary EISZ Consortium user
on 27 February 2018
not clear that by increasing the linear DNA pool in the cell, available
for integration to the competing double strand breaks, why the in-
cell cleaved plasmid is preferred to be integrated (at proportionally
higher rates) to nuclease-generated over to endogenous DSBs (Fig.
1B) when one compares this to circular or pre-linearized plasmids
(Supplementary Fig. S2).
The key step of the method is to use a self-cleaving plasmid that
provides both controlled and standardized in-cell cleavage and en-
hanced integration of the plasmid. Another important feature lies in
the use of targetless, low-background and effective spacers. The for-
mer characteristic was achieved by exploring some 30000 spacers
and it is necessary for the low background we observed, as well as
for general applicability. The latter probably increases the sensitivity
of our method, that is in accord with Auer et al. showing that more
efficient cleavage of the donor plasmid results in higher targeted inte-
gration in zebrafish.38
Our work also demonstrates an efficient way for targeted integra-
tion of DNA cassettes in mammalian cells without laborious con-
struction of homologous arms although without base pair precision.
Based on earlier studies it was not clear if NHEJ-cloning is also effec-
tive in mammalian cells following SpCas9 cleavage that generates
blunt ends. In attempts to enhance its efficiency, a few approaches
used compatible overhangs or edited microhomology (8 bases-long)
to the DSB site.43,44,52,67 Auer et al., building on the high activity of
NHEJ in zebrafish embryos,68–70 demonstrated high efficiency of
NHEJ-cloning without any overhangs or edited microhomology.38
However, when SpCas9 was used in mammalian cells for NHEJ-
cloning of a donor plasmid without any overhangs or edited micro-
homology, none of the attempts demonstrated highly efficient tar-
geted integration (0.17% and 0.45% or about 1%, in HEK and
CHO or HAP1 cells, respectively).45,46 Here, we successfully demon-
strated that NHEJ-cloning coupled with a self-cleaving donor plas-
mid without any pre-selection or FACS-enrichments can be
effectively applied (with up to 20–30% efficiency of integration) to
mammalian cells as well.
A recent study demonstrated targeted integration of expression
cassettes amplified by PCR, and reached targeted integration of
mCherry-containing cassettes between 1 and 5%.59 this is in agree-
ment with our results presented here using linear plasmids (Fig. 7;
Supplementary Figs S2 and S9). Interestingly, using the smaller and
brighter protein Clover, about 20% integrations were reported sug-
gesting that transfection of a linear donor DNA less than 2 kilobase,
might integrate more efficiently. While it is very promising, in the ab-
sence of measuring the actual transfection efficiencies, the widely dif-
ferent amounts of DNA used for transfections of samples and
controls, and in the absence of monitoring the decay of the transient
fluorescence with an appropriate inactive dCas9 control, it is difficult
to assess the real impact of these results. Another work demonstrated
homology independent integration, donor DNA knock-in not only in
cell culture model systems but in vivo as well.71
NHEJ-cloning is a useful tool for targeted integration when there
is no need for absolute precise joining of the DNA ends or when a se-
lection can be applied for the proper joining. Since the DNA frag-
ment can be inserted in two orientations and in three frames, only
some of the targeted integration events would result from in frame
incorporation of the donor DNA, depending on whether precise
NHEJ dominates over error-prone NHEJ or whether the actual se-
quences prefer certain deletions/insertion over others. Thus, it seems
that it is generally not efficient enough for easy protein tagging with-
out selection. Even so, a few studies reported successful application
of NHEJ-cloning to tag endogenous proteins using fluorescent
protein or other selectable markers.46,67,72 Nevertheless, it might be
more suitable for IRES tagging that is without much sensitivity for
base pair-precise insertion and thus, about every second targeted in-
tegration (one of the two orientations of the inserted DNA) is appro-
priate for proper tagging, provided that sufficiently high activity
gRNAs are employed. It is important to note that, using only one site
for in-cell linearization also results in the incorporation of bacterial,
‘junk’ DNA. In applications where avoiding the integration of ‘junk’
DNA is preferable, a more precise integration of the target gene/
DNA cassette can also be achieved by employing the design on
Figure 1A, using two cleavage sites as also demonstrated by Nakade
et al. and Lackner et al.46,72 A specifically attractive approach,
CRISPaint was developed recently, by which both the integration of
the plasmid-cleaving gRNA into the target genomic site and, by ap-
plying DNA minicircles, the insertion of bacterial DNA can be
avoided.73
NHEJ-cloning is especially attractive for its potential as a superior
substitute for random integration, to incorporate DNA cassettes to
safe-harbour sites in the genome—avoiding the positional effects of
the insertion—frequently encountered using random integration and
the laborious work for constructing homologous arms. It can be
more effective by at least one order of magnitude than random inte-
gration and provides stronger coupling between target and marker
genes (Supplementary Fig. S11), facilitating a more reliable identifi-
cation of the proper clones. Another attractive application of it is the
creation of loss-of-function alleles by the easy targeting of DNA at
endogenous loci. Using self-cleaving plasmids to disrupt genes is
comparably effective to out-of-frame indel-generation methods with
the added advantage of the invalidated alleles being labeled.
5. Conclusion
We demonstrated a versatile, yet simple approach for the identifica-
tion of the effective gRNAs using a fluorescent reporter assay with
self-cleaving plasmids. The method is capable of testing targets in
their genomic context and requires no extra cloning steps. While it
needs about 4 days longer to get the results, the method requires con-
siderably less hands-on time and it certainly will be favoured by re-
searchers who wish to avoid the use of the ‘gold-standard’ T7/
Surveyor assays. This method might generally be used for other
RNA-guided designer nucleases as well, such as Cas9-s from other
species and Cpf1 nucleases. Additionally, we showed that NHEJ-
cloning can also be used in mammalian cells for targeted integration
of donor plasmids up to 10 kb in size, with up to 30% efficiency,
without any selection or enrichment. Its further advantages as com-
pared to random integrations include being much more effective and
being able to provide stronger coupling of two DNA cassettes, such
as the one to be integrated and a selection marker.
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